• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NEURONETICS, INC. NEUROSTAR ADVANCED THERAPY; TRANSCRANIAL MAGNETIC STIMULATOR Back to Search Results
Model Number NEUROSTAR ADVANCED THERAPY V3.0
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Convulsion/Seizure (4406)
Event Date 12/05/2023
Event Type  Injury  
Event Description
Neuronetics received a call from a provider stating that one of their patients had experienced a seizure during their 30th treatment session and was subsequently taken to the emergency room.
 
Manufacturer Narrative
Provider called to report that one of their patients experienced a seizure lasting 2 minutes during their 30th treatment session and was taken to the er.Patient had tolerated all previous treatment sessions well prior to the event.Patient had been receiving an off label bilateral protocol for treatment.Patient had her mt remapped halfway through the course of treatment, as is standard protocol for the office per provider, and her treatment location shifted as a result.Patient reportedly previously suffered a fall from horseback riding which required her to be taken to the hospital though it is unknown what injury she had suffered as a result.Patient is currently on an antidepressant which could lower her seizure threshold.A week before the event, the patient was sick and took a few days off treatment and reportedly had been sleeping a lot, which may have impacted her seizure threshold.Patient has reportedly recovered well post the event and has not had any sequelae.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NEUROSTAR ADVANCED THERAPY
Type of Device
TRANSCRANIAL MAGNETIC STIMULATOR
Manufacturer (Section D)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer (Section G)
NEURONETICS, INC.
3222 phoenixville pike
malvern PA 19355
Manufacturer Contact
anna gorbunov
3222 phoenixville pike
malvern, PA 19355
MDR Report Key18411436
MDR Text Key331530067
Report Number3004824012-2023-00027
Device Sequence Number1
Product Code OBP
UDI-Device Identifier00869378000117
UDI-Public00869378000117
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K201158
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNEUROSTAR ADVANCED THERAPY V3.0
Device Catalogue Number81-01335-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/06/2023
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Treatment
FLUOXETINE 90 MG WEEKLY
Patient Outcome(s) Other;
Patient Age19 YR
Patient SexFemale
Patient Weight59 KG
Patient EthnicityHispanic
Patient RaceWhite
-
-